Results 161 to 170 of about 10,254 (215)

Monoclonal Gammopathy of Undetermined Significance and Associated Cardiovascular Outcomes in a Hospital Setting-A Fresh Perspective. [PDF]

Curr Oncol
Mustafa A, Wei C, Araji G, Niazi MRK, Grovu R, Weinberg M, Lafferty J.   +6 more
europepmc   +1 more source

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection.

Blood
Visram A, Larson D, Norman A, Dispenzieri A, Murray D, Kyle R, Rajkumar SV, Slager S, Kumar S, Vachon C.   +9 more
europepmc   +1 more source

Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma. [PDF]

Clin Hematol Int
Patel TH, Bachu R, Shrivastava T, Alrawabdeh J, Alzubi M, Hastings J, Dean H, Schinke C, Thanendrarajan S, Zangari M, Tricot G, Zhan F, Shaughnessy JD, van Rhee F, Al Hadidi S.   +14 more
europepmc   +1 more source

Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study. [PDF]

Cancer Epidemiol Biomarkers Prev
Ji M, Shih YH, Huber JH, Wang M, Feuer EJ, Etzioni R, Wang SY, Chang SH.   +7 more
europepmc   +1 more source

Coexistence of acute myeloid leukemia with a complex chromosomal translocation and monoclonal gammopathy of undetermined significance: A case report and literature review. [PDF]

Oncol Lett
Qiao X, Geng L, Tian T, Zhang J, Guo X, Qiao S.   +5 more
europepmc   +1 more source

Associations Between Patient Characteristics and Progression to Multiple Myeloma Among Patients With Monoclonal Gammopathy of Undetermined Significance: A Systematic Review. [PDF]

Clin Lymphoma Myeloma Leuk
Li Y, Hsu SH, Wang R, Theprungsirikul P, Neparidze N, Chang SH, Wang SY.   +6 more
europepmc   +1 more source

Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa. [PDF]

JNCI Cancer Spectr
Cicero KI, Dlamini X, Mavengere Y, Justman J, Nuwagaba-Biribonwoha H, Dlamini S, Dlamini M, Ngwenyama S, Ngcamphalala C, Low A, Philip NM, El-Sadr WM, Sahabo R, Abreha T, Temesgen S, Mahlalela N, Chiuzan C, Chen Y, Pan SS, Lentzsch S, Neugut AI.   +20 more
europepmc   +1 more source

Approaching hypercalcemia in monoclonal gammopathy of undetermined significance: insights from the iStopMM screening study.

Blood
Jónsdóttir ÁH, Sigurjónsdóttir HÁ, Thorsteinsdóttir S, Long TE, Sverrisdóttir IS, Eythorsson E, Óskarsson JÞ, Palsson R, Indridason OS, Viðarsson B, Onundarson PT, Ólafsson Í, Þorsteindóttir I, Agnarsson BA, Sigurðardóttir M, Jónsson Á, Hultcrantz M, Durie BGM, Harding S, Landgren O, Love TJ, Kristinsson SY, Rögnvaldsson S.   +22 more
europepmc   +1 more source

Monoclonal Gammopathy of Undetermined Significance

New England Journal of Medicine, 2007
Monoclonal gammopathy of undetermined significance (MGUS) is a precancerosis comprising two different kinds of cancer: lymphoid/lymphoplasmocytoid MGUS and plasma cell MGUS that represents about 85% of all MGUS cases. This type of MGUS has low but persistent tendency to transform to malignant disease, mainly multiple myeloma (MM), with frequency of ...
MINISOLA, Salvatore, PEPE, JESSICA, E. Romagnoli   +2 more
core   +4 more sources